EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Nintedanib on Orofacial Fibroblasts and Myoblasts

Zhihao Wang iD, Frank A D T G Wagener iD, Edwin M Ongkosuwito iD, Johannes W Von den Hoff iD

Biomolecules · 2026

DOI: 10.3390/biom16020316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Zhihao Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Orthodontics and Craniofacial Biology, Research Institute for Medical Innovation, Radboud University Medical Centre, 6525EX …. Hauptthemen laut MEDLINE: Indoles, Fibroblasts, Myoblasts. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Osteology Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following surgical interventions or acquired trauma, fibrosis often inhibits muscle and skin regeneration. Nintedanib, an antifibrotic drug for lung fibrosis, may help prevent orofacial fibrosis. This study evaluates Nintedanib’s potential for inhibiting myofibroblast differentiation and affecting the fusion of orofacial myoblasts into myotubes. Rat gingival fibroblasts and satellite cells (SCs) were isolated and cultured with TGF-β1 to induce myofibroblast differentiation and prevent myotube formation. Adding 1 and 10 ng/mL TGF-β1 significantly increased the percentage of myofibroblasts. Although Nintedanib did not affect the percentage of myofibroblasts, it strongly decreased the total number of fibroblasts and myofibroblasts. Additionally, Nintedanib at a concentration of 2 μM markedly reduced the expression of Ki-67 in fibroblasts and myofibroblasts. In the SC cultures, 0.2 ng/mL TGF-β1 reduced the fusion index of SCs. Treatment with 2 μM Nintedanib significantly increased the fusion index of SCs. Furthermore, MyoD and MyoG gene expression in SCs was also significantly enhanced by Nintedanib at a concentration of 2 μM. Nintedanib promotes myotube formation while inhibiting (myo)fibroblast proliferation. This dual action stresses its potential as an anti-fibrotic therapy after orofacial surgery or traumatic injury affecting muscle tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolesFibroblastsMyoblastsAnimalsCell DifferentiationRatsMyoD ProteinCell ProliferationMyogeninCells, CulturedTransforming Growth Factor beta1MyofibroblastsGingivaSatellite Cells, Skeletal MuscleMuscle Fibers, Skeletal

Stichwörter der Autor:innen

myofibroblastmyotubenintedanibsatellite cells

Substanzen

IndolesnintedanibMyoD ProteinMyogeninTransforming Growth Factor beta1Myog protein, ratMyoD1 myogenic differentiation protein

Autor:innen und Institutionen

  • Department of Dentistry, Orthodontics and Craniofacial Biology, Research Institute for Medical Innovation, Radboud University Medical Centre, 6525EX Nijmegen, The Netherlands.
  • Department of Implant Alveolar Surgery, Stomatological Center, Weifang People's Hospital, Weifang 261000, China.

ORCID-Profile: Zhihao Wang, Frank A D T G Wagener, Edwin M Ongkosuwito, Johannes W Von den Hoff

Förderung

  • Osteology Foundation

Zitieren

APA

Wang, Z., Wagener, F. A. D. T. G., Ongkosuwito, E. M., & Von den Hoff, J. W. (2026). Effects of Nintedanib on Orofacial Fibroblasts and Myoblasts. Biomolecules. https://doi.org/10.3390/biom16020316

Vancouver

Wang Z, Wagener FADTG, Ongkosuwito EM, Von den Hoff JW. Effects of Nintedanib on Orofacial Fibroblasts and Myoblasts. Biomolecules. 2026. doi:10.3390/biom16020316

BibTeX
@article{Wang2026,
  author = {Wang, Zhihao and Wagener, Frank A D T G and Ongkosuwito, Edwin M and Von den Hoff, Johannes W},
  title = {Effects of Nintedanib on Orofacial Fibroblasts and Myoblasts},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16020316}
}
Kostenlos starten →